| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K79669418 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.05 |
| mRNA | pitstop2 | CTRPv2 | pan-cancer | AAC | -0.094 | 0.05 |
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.05 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | -0.066 | 0.05 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.1 | 0.05 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.068 | 0.05 |
| mRNA | BRD-K29313308 | CTRPv2 | pan-cancer | AAC | -0.073 | 0.06 |
| mRNA | phenformin | GDSC1000 | pan-cancer | AAC | -0.061 | 0.06 |
| mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | -0.07 | 0.06 |
| mRNA | MK-0752 | CTRPv2 | pan-cancer | AAC | -0.074 | 0.06 |